Status:
UNKNOWN
Optic Coherence Tomography in Patients With Amyotrophic Lateral Sclerosis
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Amyotrophic Lateral Sclerosis (ALS) is an adult-onset, devastating, neurodegenerative disease characterized by the loss of cortical, brain stem, and spinal motor neurons. Visual evoked potentials stud...
Eligibility Criteria
Inclusion
- Diagnosis of ALS according to the El Escorial criteria.
- Age 18 years to 80 years old
- Disease duration less than 36 months
- Patients logistically able to attend and be evaluated at baseline, 3 and 6 months
Exclusion
- Patients with diabetes mellitus
- Patients with glaucoma, refractive errors of ± 6 diopters or more, or other ophthalmologic disorders such as media opacities that could interfere with retinal OCT assessment
Key Trial Info
Start Date :
January 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 28 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03377868
Start Date
January 3 2018
End Date
September 28 2018
Last Update
December 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.